Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients
- 12 March 2019
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 143 (1) , 129-136
Abstract
Corticosteroids are commonly used to alleviate symptoms from cerebral vasogenic edema in glioblastoma (GBM) patients. This study evaluated the impact of overall corticosteroid exposure during chemoradiotherapy (CRT) on acute severe lymphopenia (ASL) and survival outcomes of GBM patients.Keywords
This publication has 18 references indexed in Scilit:
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsNature Medicine, 2018
- Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for GlioblastomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapyJournal of Neuro-Oncology, 2017
- In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatmentOncoImmunology, 2017
- Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastomaJournal of Neuro-Oncology, 2016
- Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade GliomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and TemozolomideClinical Cancer Research, 2011
- Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histologyNeuro-Oncology, 2010
- Malignant Gliomas in AdultsNew England Journal of Medicine, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005